Vis enkel innførsel

dc.contributor.authorZahl, Per-Henrik
dc.contributor.authorHemstrøm, Ørjan
dc.contributor.authorJohansen, Rune
dc.contributor.authorMamelund, Svenn-Erik
dc.date.accessioned2024-03-19T06:39:19Z
dc.date.available2024-03-19T06:39:19Z
dc.date.created2023-11-06T13:29:58Z
dc.date.issued2023
dc.identifier.issn1876-0341
dc.identifier.urihttps://hdl.handle.net/11250/3122977
dc.description.abstractBackground Norway and Sweden picked two different ways to mitigate the dissemination of the SARS-CoV-2 virus. Norway introduced the strictest lockdown in Europe with strict border controls and intense virus tracking of all local outbreaks while Sweden did not. That resulted in 477 COVID-19 deaths (Norway) and 9737 (Sweden) in 2020, respectively. Methods Weekly number of COVID-19 related deaths and total deaths for 2020–22 were collected as well as weekly number of deaths for 2015–19 which were used as controls when calculating excess mortality. During the first 12–18 months with high rate of virus transmission in the society, excess mortality rates were used as substitute for COVID-19 deaths. When excess mortality rates later turned negative because of mortality displacement, COVID-19 deaths adjusted for bias due to overreporting were used. Results There were 17521 COVID-19 deaths in Sweden and 4272 in Norway in the study period. The rate ratio (RR) of COVID-19 related deaths in Sweden vs. Norway to the end of week 43, 2022, was 2.11 (95% CI 2.05–2.19). RR of COVID-19 related deaths vs. excess number of deaths were 2.5 (Sweden) and 1.3 (Norway), respectively. RR of COVID-19 deaths in Sweden vs. Norway after adjusting for mortality displacement and lockdown, was 1.35 (95% CI 1.31–1.39), corresponding to saving 2025 life in Norway. If including all deaths in 2022, RR= 1.28 (95% CI 1.24–1.31). Conclusions Both COVID-19 related mortality and excess mortality rates are biased estimates. When adjusting for bias, mortality differences declined over time to about 30% higher mortality in Sweden after 30 months with pandemics and at the cost of 12 million € per prevented death in Norway.en_US
dc.language.isoengen_US
dc.relation.urihttps://www.sciencedirect.com/science/article/pii/S1876034123003714?via%3Dihub
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleMortality in Norway and Sweden during the COVID-19 pandemic 2020 – 22: A comparative studyen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doihttps://doi.org/10.1016/j.jiph.2023.10.033
dc.identifier.cristin2192663
dc.source.journalJournal of Infection and Public Healthen_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal